Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-004950

Chief Medical Officer gave up 1,960 shares (to pay taxes)

  • Chief Medical Officer acquired 6,265 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bowden Christopher Chief Medical Officer 2019-01-20 Option exercise +6,265 7,189 D
Bowden Christopher Chief Medical Officer 2019-01-22 Shares withheld for taxes −1,960 $52.82 $103,527 5,229 D
Derivatives
Bowden Christopher Chief Medical Officer 2019-01-20 Option exercise · Performance share unit −6,265 0 D
Loading xslF345X03/doc4.xml…